Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Instantaneous wave-free ratio and fractional flow reserve in clinical practice.

Pisters R, Ilhan M, Veenstra LF, Gho BCG, Stein M, Hoorntje JCA, Rasoul S.

Neth Heart J. 2018 Jun 19. doi: 10.1007/s12471-018-1125-1. [Epub ahead of print]

2.

Comparison of Outcomes and Intervention Among Patients With Non-ST-Segment Elevation Acute Myocardial Infarction of Those With a Left Circumflex Versus Those With a Non-Left Circumflex-Related Coronary Artery (From the ELISA-3 Trial).

Badings EA, Hermanides RS, The SHK, Dambrink JE, Rasoul S, Van Wijngaarden J, Van 't Riet E, Kolkman E, Remkes WS, Tjeerdsma G, Van Der Wielen MLJ, Lok DJA, Suryapranata H, Van 't Hof AWJ.

Am J Cardiol. 2018 May 15;121(10):1123-1128. doi: 10.1016/j.amjcard.2018.01.031. Epub 2018 Feb 21.

PMID:
29606324
3.

Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome.

Badings EA, Remkes WS, The SH, Dambrink JE, Tjeerdsma G, Rasoul S, Timmer JR, van der Wielen ML, Lok DJ, Hermanides RS, Van Wijngaarden J, Suryapranata H, van 't Hof AW.

Open Heart. 2017 Mar 2;4(1):e000538. doi: 10.1136/openhrt-2016-000538. eCollection 2017.

4.

Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction.

Remkes WS, Badings EA, Hermanides RS, Rasoul S, Dambrink JE, Koopmans PC, The SH, Ottervanger JP, Gosselink AT, Hoorntje JC, Suryapranata H, van 't Hof AW.

Open Heart. 2016 Nov 17;3(2):e000455. eCollection 2016.

5.

Well begun is half done.

Pisters R, de Booij M, Reuchlin O, Rasoul S.

Neth Heart J. 2016 Dec;24(12):759-760. No abstract available.

6.

Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the ELISA-3 trial.

Badings EA, Remkes WS, The SH, Dambrink JE, Tjeerdsma G, Rasoul S, Timmer JR, van der Wielen ML, Lok DJ, Hermanides R, van Wijngaarden J, Suryapranata H, van 't Hof AW.

Catheter Cardiovasc Interv. 2016 Nov;88(5):755-764. doi: 10.1002/ccd.26719. Epub 2016 Aug 27.

PMID:
27567144
7.

Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.

Roolvink V, Ibáñez B, Ottervanger JP, Pizarro G, van Royen N, Mateos A, Dambrink JE, Escalera N, Lipsic E, Albarran A, Fernández-Ortiz A, Fernández-Avilés F, Goicolea J, Botas J, Remkes W, Hernandez-Jaras V, Kedhi E, Zamorano JL, Navarro F, Alfonso F, García-Lledó A, Alonso J, van Leeuwen M, Nijveldt R, Postma S, Kolkman E, Gosselink M, de Smet B, Rasoul S, Piek JJ, Fuster V, van 't Hof AWJ; EARLY-BAMI Investigators.

J Am Coll Cardiol. 2016 Jun 14;67(23):2705-2715. doi: 10.1016/j.jacc.2016.03.522. Epub 2016 Apr 3.

8.

Timing of intervention in high-risk non-ST-elevation acute coronary syndromes in PCI versus non-PCI centres : Sub-group analysis of the ELISA-3 trial.

Badings EA, Remkes WS, Dambrink JH, The SH, Van Wijngaarden J, Tjeerdsma G, Rasoul S, Timmer JR, van der Wielen ML, Lok DJ, van 't Hof AW.

Neth Heart J. 2016 Mar;24(3):181-7. doi: 10.1007/s12471-015-0801-7.

9.

Multivessel revascularisation versus infarct-related artery only revascularisation during the index primary PCI in STEMI patients with multivessel disease: a meta-analysis.

Rasoul S, van Ommen V, Vainer J, Ilhan M, Veenstra L, Erdem R, Ruiters LA, Theunissen R, Hoorntje JC.

Neth Heart J. 2015 Apr;23(4):224-31. doi: 10.1007/s12471-015-0674-9.

10.

Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.

Roolvink V, Rasoul S, Ottervanger JP, Dambrink JH, Lipsic E, van der Horst IC, de Smet B, Kedhi E, Marcel Gosselink AT, Piek JJ, Sanchez-Brunete V, Ibanez B, Fuster V, Van't Hof AW; EARLY-BAMI investigators.

Am Heart J. 2014 Nov;168(5):661-6. doi: 10.1016/j.ahj.2014.07.015. Epub 2014 Jul 28.

PMID:
25440793
11.

Impact of out-of-hospital cardiac arrest due to ventricular fibrillation in patients with ST-elevation myocardial infarction admitted for primary percutaneous coronary intervention: Impact of ventricular fibrillation in STEMI patients.

Demirel F, Rasoul S, Elvan A, Ottervanger JP, Dambrink JH, Gosselink AT, Hoorntje JC, Ramdat Misier AR, van 't Hof AW.

Eur Heart J Acute Cardiovasc Care. 2015 Feb;4(1):16-23. doi: 10.1177/2048872614547448. Epub 2014 Aug 11.

PMID:
25114328
12.

Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.

Remkes WS, Somi S, Roolvink V, Rasoul S, Ottervanger JP, Gosselink AT, Hoorntje JC, Dambrink JH, de Boer MJ, Suryapranata H, van 't Hof AW; Acute Myocardial Infarction Study Group.

JACC Cardiovasc Interv. 2014 Jul;7(7):751-8. doi: 10.1016/j.jcin.2014.02.012.

13.

Angiography guided therapy in an all comer acute coronary syndrome patient population.

Rasoul S, Roolvink V, Ottervanger JP, Gosselink AT, Dambrink JH, de Boer MJ, Hoorntje JC, Suryapranata H, van 't Hof AW.

Int J Cardiol. 2013 Oct 12;168(5):4900-2. doi: 10.1016/j.ijcard.2013.07.103. Epub 2013 Jul 26. No abstract available.

PMID:
23896539
14.

Recurrent acute coronary syndrome due to coronary artery spasm in different coronary arteries.

Rasoul S, Dambrink JE.

J Cardiol Cases. 2013 Jul 11;8(3):95-98. doi: 10.1016/j.jccase.2013.05.007. eCollection 2013 Sep.

15.

Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial.

Badings EA, The SH, Dambrink JH, van Wijngaarden J, Tjeerdsma G, Rasoul S, Timmer JR, van der Wielen ML, Lok DJ, van 't Hof AW.

EuroIntervention. 2013 May 20;9(1):54-61. doi: 10.4244/EIJV9I1A9.

16.

Circumflex artery related myocardial infarction: less reperfusion therapy and large infarct size.

Roolvink V, Rasoul S, Ottervanger JP, Dambrink JH, Gosselink M, Hoorntje JC, Hermanides R, Suryapranata H, van 't Hof AW.

Int J Cardiol. 2013 Sep 30;168(2):1624-6. doi: 10.1016/j.ijcard.2013.01.014. Epub 2013 Feb 8. No abstract available.

PMID:
23398822
17.

[Myocardial infarction without ECG abnormalities: consider occlusion of the circumflex coronary artery].

Rasoul S, Roolvink V, Ottervanger JP, van 't Hof A.

Ned Tijdschr Geneeskd. 2012;156(13):A4158. Dutch.

PMID:
22456289
18.

Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.

Tricoci P, Newby LK, Hasselblad V, Kong DF, Giugliano RP, White HD, Théroux P, Stone GW, Moliterno DJ, Van de Werf F, Armstrong PW, Prabhakaran D, Rasoul S, Bolognese L, Durand E, Braunwald E, Califf RM, Harrington RA.

Circ Cardiovasc Qual Outcomes. 2011 Jul;4(4):448-58. doi: 10.1161/CIRCOUTCOMES.110.960294. Epub 2011 Jun 28. Review.

PMID:
21712522
19.

Mycotic aneurysm of the aortic arch.

Rasoul S, Jaspers RM Jr, van Wijngaarden J.

Neth Heart J. 2011 Sep;19(9):397-8. doi: 10.1007/s12471-011-0109-1. No abstract available.

20.

Impact of diabetes on outcome in patients with non-ST-elevation myocardial infarction.

Rasoul S, Ottervanger JP, Timmer JR, Yokota S, de Boer MJ, van 't Hof AW; Zwolle myocardial infarction study group.

Eur J Intern Med. 2011 Feb;22(1):89-92. doi: 10.1016/j.ejim.2010.09.014. Epub 2010 Nov 4.

PMID:
21238901

Supplemental Content

Loading ...
Support Center